Further guidance is needed to protect patients from "sycophantic" genAI documentation outputs that influence medical decisions, and researchers are asking FDA "to clarify its oversight before summarization becomes a part of routine patient care."
Subscribe to:
Post Comments (Atom)
< + > Hyland Brings Enterprise Content Management to Pathology with Tribun
Michael Campbell, Chief Product Officer at Hyland , is blunt about where digital pathology struggles today. Adoption is moving, but the oper...
No comments:
Post a Comment